The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) before surgery rose 16-fold among patients undergoing metabolic and bariatric surgery from 2020 to 2024.

Familial clustering was identified in primary hyperparathyroidism, as first-degree relatives were at higher risk than control patients.

The addition of sotatercept, an activin-signaling inhibitor, to background therapy results in a lower risk for clinical worsening among adults with pulmonary arterial hypertension (PAH) who were ...

High intake of sugar-sweetened beverages (SSBs) and low- or non-sugar-sweetened beverages (LNSSBs) is associated with an increased risk for incident metabolic dysfunction-associated steatotic liver ...

Approximately 29% of patients with acute COVID-19 infection developed long COVID, with female sex, diabetes, reinfection, and hospitalization predicting delayed recovery.

Use of ambient artificial intelligence (AI) scribes is associated with a reduction in burnout and cognitive task load among clinicians.

Transgender patients with heart failure who receive treatment at urban hospitals, compared with rural hospitals, have worse outcomes.

The Food and Drug Administration has approved Enoby, a biosimilar to Prolia, and Xtrenbo, a biosimilar to Xgeva.

Pediatric Graves disease incidence was highest among adolescent girls, with incidence peaking among children aged 13 to 17 years.

There is lower risk for mortality in patients with cardio-renal-metabolic multimorbidity who maintain hematologic parameters within optimal ranges.

The Endocrine Society and European Society of Endocrinology issued recommendations for the management of preexisting diabetes ...

The use of GLP-1RAs may improve RA disease activity and cardiovascular risk profiles among patients with overweight or obesity.